Skip to main content

Lupin seeks to market generic Lo Loestrin Fe

7/26/2011

NEW YORK — Generic drug maker Lupin is seeking approval for a generic version of a contraceptive made by Warner Chilcott, according to published reports.


Reuters reported that Lupin had applied for approval of a generic version of Lo Loestrin Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets), an oral contraceptive.


The Food and Drug Administration approved Lo Loestrin Fe in October 2010, and it’s covered by patents set to expire in July 2014 and February 2029, according to the FDA. Warner Chilcott expects to file a patent infringement suit against Lupin, according to Reuters.

X
This ad will auto-close in 10 seconds